By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Itonis, Inc.

Itonis, Inc. (ITNS)

OTC Currency in USD
$0.00
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$457.02K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.00
52 Week Range

ITNS Stock Price Chart

Explore Itonis, Inc. interactive price chart. Choose custom timeframes to analyze ITNS price movements and trends.

ITNS Company Profile

Discover essential business fundamentals and corporate details for Itonis, Inc. (ITNS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Distribution

IPO Date

21 Feb 2007

Employees

3.00

CEO

Mark H. Cheung

Description

Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.

ITNS Financial Timeline

Browse a chronological timeline of Itonis, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

ITNS Stock Performance

Access detailed ITNS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run